Showing results (381-390 of 462) with videos related to

Sort By:
Pageof 47
AJNR. American Journal of Neuroradiology|February 17, 2018
Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid CancerN U Patel, K E Lind, K McKinney, et al.
Plos One|September 13, 2011
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptomeStine A Danielsen, Lina Cekaite, Trude H Ågesen, et al.
Molecular Cancer|February 5, 2005
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylationGuro E Lind, Rolf I Skotheim, Mario F Fraga, et al.
International Journal of Cancer|August 26, 2011
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcomeSolveig Sirnes, Jarle Bruun, Matthias Kolberg, et al.
Epigenetics|March 17, 2011
DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (Connexin45) by promoter hypermethylation in colorectal cancerSolveig Sirnes, Hilde Honne, Deeqa Ahmed, et al.
Plos One|June 9, 2016
D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte CulturesAlan C Foster, Jill Farnsworth, Genevieve E Lind, et al.
Breast Cancer Research and Treatment|January 19, 2013
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypesBárbara Mesquita, Paula Lopes, Ana Rodrigues, et al.
Epigenetics|December 24, 2013
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphomaNicole Bethge, Ragnhild A Lothe, Hilde Honne, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Assessment of coagulation system activation using spot urine measurementsS E Lind, S Goldshteyn, C P Barry, et al.
International Journal of Cancer|December 17, 2011
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancerAnita Sveen, Anne Cathrine Bakken, Trude H Ågesen, et al.
Pageof 47